MVP
BIIB icon

Missouri Valley Partners’s Biogen BIIB Stock Holding History

Missouri Valley Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$2.22M Buy
9,239
+803
+10% +$180K 0.84% 45
2013
Q2 		$1.81M Buy
+8,436
New +$1.8M 0.7% 58

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Missouri Valley Partners's BIIB Position: Q3 2013 in Review

Missouri Valley Partners increased its Biogen (BIIB) stake by 9.5% in Q3 2013, buying an estimated $180K and bringing the position to 9,239 shares worth $2.22M. The position accounts for 0.84% of the portfolio, ranked #45.

Missouri Valley Partners first reported a position in BIIB in Q2 2013 and has held it in 2 quarters since. 656 funds tracked by Wall St. Rank hold BIIB as of Q3 2013.

  • Missouri Valley Partners held 9,239 shares of Biogen worth $2.22M as of Q3 2013.
  • Missouri Valley Partners bought 803 Biogen shares in Q3 2013, an estimated $180K.
  • Biogen made up 0.84% of Missouri Valley Partners's portfolio in Q3 2013, its #45 holding.
  • Missouri Valley Partners first reported a position in Biogen in Q2 2013 and has held it in 2 quarters since.
  • 656 funds tracked by Wall St. Rank held Biogen as of Q3 2013.

Based on Missouri Valley Partners's 13F filing for Q3 2013, filed 13 Nov 2013.